Systemic inflammation response index mediates the association between relative fat mass and psoriasis risk: a population-based study.

Xinyi Shao, Jun Yu, Qian Liu, Yidian Fu, Aijun Chen, Genlong Bai, Jingbo Zhang
Author Information
  1. Xinyi Shao: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  2. Jun Yu: Department of Dermatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  3. Qian Liu: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  4. Yidian Fu: Graduate School of Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
  5. Aijun Chen: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. chenaijun@hospital.cqmu.edu.cn.
  6. Genlong Bai: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 934147726@qq.com.
  7. Jingbo Zhang: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 49554556samael@gmail.com.

Abstract

BACKGROUND: Psoriasis, a prevalent autoimmune skin condition, considerably impairs the quality of life of those who are affected by it. Several studies have demonstrated that obesity significantly contributes to both the onset and progression of psoriasis. Relative fat mass (RFM), a novel obesity index, provides a more precise measure by incorporating both height and waist circumference (WC). The aim of this study was to investigate the association between RFM and psoriasis risk, taking into account the intermediary role played by the systemic inflammation response index (SIRI).
METHODS: The cross-sectional study assessed data from 8,479 adults who participated in the NHANES cycles from 2003 to 2006 and 2009 to 2014. To examine the association between RFM and psoriasis, both multivariate logistic regression model and restricted cubic spline (RCS) analyses were conducted. A mediation analysis was used to clarify the role of SIRI in the association between RFM and psoriasis.
RESULTS: Higher RFM was significantly associated with a 5% higher risk of developing psoriasis (odds ratio [OR] = 1.05, 95% confidence interval [CI]:1.02-1.08), with RFM quartiles indicating a significant trend (P  < 0.05). The SIRI demonstrated a significant mediating effect on the RFM-psoriasis relationship (mediation effect ratio = 5.02%).
CONCLUSION: Elevated RFM are associated with an increased prevalence of psoriasis. RFM has the potential to be a beneficial anthropometric measure for more accurately predicting psoriasis risk.

Keywords

References

  1. J Clin Med. 2023 Jan 13;12(2): [PMID: 36675592]
  2. Exp Dermatol. 2011 Feb;20(2):81-7 [PMID: 21255085]
  3. Cell Death Dis. 2022 Jan 24;13(1):81 [PMID: 35075118]
  4. Sci Rep. 2018 Jul 20;8(1):10980 [PMID: 30030479]
  5. Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C375-C391 [PMID: 33356944]
  6. JAMA. 2020 May 19;323(19):1945-1960 [PMID: 32427307]
  7. Clin Dermatol. 2018 Jan - Feb;36(1):21-28 [PMID: 29241748]
  8. Lipids Health Dis. 2024 Oct 31;23(1):354 [PMID: 39482681]
  9. Nutr Metab Cardiovasc Dis. 2024 Mar;34(3):738-754 [PMID: 38161128]
  10. Autoimmun Rev. 2020 Mar;19(3):102468 [PMID: 31927086]
  11. Lipids Health Dis. 2024 Nov 13;23(1):373 [PMID: 39538202]
  12. Obes Res Clin Pract. 2014 May-Jun;8(3):e201-98 [PMID: 24847661]
  13. Front Endocrinol (Lausanne). 2020 Jan 29;10:935 [PMID: 32063886]
  14. J Clin Med. 2023 Jan 31;12(3): [PMID: 36769776]
  15. PLoS One. 2019 Dec 31;14(12):e0226767 [PMID: 31891616]
  16. PLoS Med. 2019 Jan 31;16(1):e1002739 [PMID: 30703100]
  17. JAMA Dermatol. 2022 Jul 1;158(7):745-753 [PMID: 35612851]
  18. J Affect Disord. 2024 Jul 1;356:323-328 [PMID: 38614443]
  19. Sci Rep. 2024 Aug 6;14(1):18251 [PMID: 39107485]
  20. Lancet. 2021 Apr 3;397(10281):1301-1315 [PMID: 33812489]
  21. Br J Dermatol. 2020 Apr;182(4):880-888 [PMID: 31276189]
  22. J Am Acad Dermatol. 2015 Jun;72(6):961-7.e5 [PMID: 25882886]
  23. J Am Acad Dermatol. 2009 Mar;60(3):394-401 [PMID: 19231638]
  24. Nat Commun. 2015 Jul 15;6:7687 [PMID: 26173479]
  25. Dermatol Ther. 2022 Sep;35(9):e15685 [PMID: 35790061]
  26. An Bras Dermatol. 2019 Mar-Apr;94(2):192-197 [PMID: 31090824]
  27. Immunity. 2023 Aug 8;56(8):1844-1861.e6 [PMID: 37478855]
  28. Nat Immunol. 2009 Mar;10(3):314-24 [PMID: 19182808]

MeSH Term

Humans
Psoriasis
Male
Female
Middle Aged
Adult
Cross-Sectional Studies
Inflammation
Waist Circumference
Risk Factors
Obesity
Body Mass Index
Odds Ratio
Aged
Logistic Models

Word Cloud

Created with Highcharts 10.0.0psoriasisRFMindexstudyassociationfatmassriskinflammationresponseSIRIPsoriasisdemonstratedobesitysignificantlyRelativemeasureroleNHANESmediationassociated05significanteffectSystemicBACKGROUND:prevalentautoimmuneskinconditionconsiderablyimpairsqualitylifeaffectedSeveralstudiescontributesonsetprogressionnovelprovidespreciseincorporatingheightwaistcircumferenceWCaiminvestigatetakingaccountintermediaryplayedsystemicMETHODS:cross-sectionalassesseddata8479adultsparticipatedcycles2003200620092014examinemultivariatelogisticregressionmodelrestrictedcubicsplineRCSanalysesconductedanalysisusedclarifyRESULTS:Higher5%higherdevelopingoddsratio[OR] = 195%confidenceinterval[CI]:102-108quartilesindicatingtrendP< 0mediatingRFM-psoriasisrelationshipratio = 502%CONCLUSION:Elevatedincreasedprevalencepotentialbeneficialanthropometricaccuratelypredictingmediatesrelativerisk: apopulation-basedCross-sectional

Similar Articles

Cited By

No available data.